Commonwealth Consolidated Acts

[Index] [Table] [Search] [Search this Act] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

NARCOTIC DRUGS ACT 1967 - SECT 10D

Conditions that may be prescribed or imposed

  (1)   The conditions of a medicinal cannabis licence that may be prescribed or imposed may relate to, but are not limited to, the following:

  (a)   matters relating to the activities authorised by the licence, including activities authorised in accordance with a permit;

  (b)   the supply, delivery, dealing in any way with, transportation and disposal of:

  (i)   cannabis plants cultivated or obtained under the licence in accordance with a permit; or

  (ii)   cannabis or cannabis resin produced under the licence in accordance with a permit; or

  (iii)   a cannabis drug manufactured under the licence in accordance with a permit;

  (c)   the use of names or symbols that may suggest or imply a particular effect upon humans of a cannabis drug or a narcotic preparation that contains such a drug, but not so as to prevent the specification of factual material;

  (d)   waste disposal;

  (e)   the destruction of cannabis plants, parts of cannabis plants, cannabis drugs, narcotic preparations that contain such a drug or by - products of cannabis drugs or such narcotic preparations, including the specification of the circumstances in which:

  (i)   destruction must not occur without the Secretary's permission; or

  (ii)   destruction must occur;

  (f)   documentation and record - keeping in respect of activities to which the licence relates;

  (g)   facilities and containment in respect of the cultivation, production or manufacture authorised by the licence, including requirements relating to the following:

  (i)   the security of premises;

  (ii)   the certification of premises or facilities to specified containment levels;

  (h)   the safety, security and surveillance of premises;

  (i)   access to premises on which activities authorised by the licence are, are to be, or have been, undertaken;

  (j)   measures to manage risks posed to the health and safety of people, or to the environment;

  (k)   data collection, including studies to be conducted;

  (l)   information that is to be provided, whether on request by the Secretary, on a regular basis or on the occurrence of a particular event, and the times at which, or periods within which, such information is to be provided;

  (m)   the taking of samples of any thing to which the licence relates and the removal and testing of such samples;

  (n)   auditing and reporting;

  (o)   actions to be taken in case of loss, theft, spoilage or destruction (however occurring) of:

  (i)   cannabis plants cultivated or obtained under, or purportedly under, the licence; or

  (ii)   cannabis or cannabis resin produced under, or purportedly under, the licence; or

  (iii)   a cannabis drug manufactured under, or purportedly under, the licence; or

  (iv)   a narcotic preparation that contains such a drug;

  (p)   compliance with a code of practice;

  (q)   contingency planning;

  (r)   matters relating to the employment of staff or the engagement of contractors;

  (s)   advertising to the public by the licence holder in relation to cannabis plants, a cannabis drug or a narcotic preparation that contains such a drug;

  (t)   the labelling of a cannabis drug.

  (2)   The conditions of a medicinal cannabis licence that authorises the cultivation of cannabis plants, or the production of cannabis or cannabis resin, may include conditions requiring the licence holder to be adequately insured against any loss, damage, or injury that may be caused to human health, property or the environment by activities undertaken under (or purportedly under) the licence.



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback